Optimizing long-acting injectable antipsychotic safety and care continuity through documentation best practices.
Saved in:
| Title: | Optimizing long-acting injectable antipsychotic safety and care continuity through documentation best practices. |
|---|---|
| Authors: | Throneberry AR; Department of Clinical Pharmacy & Translational Science, University of Tennessee Health Science Center College of Pharmacy, Nashville, TN, United States., Burk BG; Department of Pharmacy, University of Alabama at Birmingham Medical Center, Birmingham, AL, United States.; Department of Psychiatry and Behavioral Neurobiology, University of Alabama Max Heersink School of Medicine, Birmingham, AL, United States., Pruett BS; Department of Psychiatry and Behavioral Neurobiology, University of Alabama Max Heersink School of Medicine, Birmingham, AL, United States. |
| Source: | Frontiers in psychiatry [Front Psychiatry] 2025 Sep 01; Vol. 16, pp. 1659290. Date of Electronic Publication: 2025 Sep 01 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-0640 |
|---|---|
| DOI: | 10.3389/fpsyt.2025.1659290 |
